Eluxadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: Results of 2 Randomized, Double-blind, Placebo-Controlled Phase 3 Clinical Trials of Efficacy and Safety

被引：0
|
作者：
Lembo, Anthony
Dove, Scott
Andrae, David
Davenport, J. Michael
McIntyre, Gail
Almenoff, June
Covington, Paul S.
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
929d
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [21] The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial
    Bai, Tao
    Zeng, Haoyu
    Long, Yanqin
    Li, Xiaoqing
    Sun, Xiaohong
    Lan, Yu
    Gao, Lingling
    Zhang, Lu
    Feng, Zenghui
    Hou, Xiaohua
    TRIALS, 2020, 21 (01)
  • [22] Efficacy and Safety of Drotaverine Hydrochloride in Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Study
    Rai, Ramesh R.
    Dwivedi, Manisha
    Kumar, Nirmal
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2014, 20 (06): : 378 - 382
  • [23] Efficacy and Safety of Tenapanor in Patients With Constipation Predominant Irritable Bowel Syndrome: A 12-week, Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial
    Chey, William D.
    Lembo, Anthony J.
    Korner, Paul
    Yan, Andrew
    Rosenbaum, David P.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S226 - S227
  • [24] Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: A randomized placebo-controlled trial
    Leung, Wai K.
    Wu, Justin C. Y.
    Liang, S. M.
    Chan, L. S.
    Chan, Francis K. L.
    Xie, He
    Fung, Sara S. L.
    Hui, Aric J.
    Wong, Vincent W. S.
    Che, Chun-Tao
    Sung, Joseph J. Y.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (07): : 1574 - 1580
  • [25] Efficacy and Safety of ASP7147, a Bombesin-2 Receptor Antagonist, in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): Results of a Multicenter, Double-Blind, Placebo-Controlled Trial
    Lembo, Anthony
    Huber, James
    Schinagl, Robert M.
    Waters, Stephen J.
    Harris, M. Scott
    GASTROENTEROLOGY, 2015, 148 (04) : S69 - S69
  • [26] Evaluating the Safety and Efficacy of Eluxadoline for Treating Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis
    Shah, Eric D.
    Rezaie, Ali
    Pimentel, Mark
    GASTROENTEROLOGY, 2016, 150 (04) : S694 - S694
  • [27] Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial
    Zheng, Ya
    Ching, Jessica
    Cheng, Chung Wah
    Lam, Wai Ching
    Chan, Kam Leung
    Zhang, Xuan
    Lam, Pui Yan
    Wu, Xing Yao
    Zhong, Linda L. D.
    Cao, Pei Hua
    Lo, Cho Wing
    Cheong, Pui Kuan
    Lin, Zhixiu
    Koh, Matthew
    Wu, Justin
    Bian, Zhao Xiang
    CHINESE MEDICINE, 2021, 16 (01)
  • [28] Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial
    Ya Zheng
    Jessica Ching
    Chung Wah Cheng
    Wai Ching Lam
    Kam Leung Chan
    Xuan Zhang
    Pui Yan Lam
    Xing Yao Wu
    Linda L. D. Zhong
    Pei Hua Cao
    Cho Wing Lo
    Pui Kuan Cheong
    Zhixiu Lin
    Matthew Koh
    Justin Wu
    Zhao Xiang Bian
    Chinese Medicine, 16
  • [29] EFFICACY OF RIFAXIMIN ON BLOATING IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D): A POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS
    Lacy, Brian E.
    Pimentel, Mark
    Chang, Christopher
    Heimanson, Zeev
    Lembo, Anthony J.
    GASTROENTEROLOGY, 2018, 154 (06) : S498 - S499
  • [30] EFFICACY OF PROBIOTICS FOR IRRITABLE BOWEL SYNDROME: A META-ANALYSIS OF RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS
    Shi, Lubo
    Zhang, Wenxue
    Wu, Shanshan
    Zhou, Minsi
    Wu, Jing
    Shi, Haiyun
    GUT, 2022, 71 : A159 - A160
12345